物理性质
- 熔点−94 °C(文献)
- 沸点4 °C(文献)
- 闪点-34 °C
- 密度3.3 g/mL at 25 °C(文献)
- PSA:0.0
- LogP:1.0111
- 折射率1.4432
- 蒸汽压1420 mm Hg ( 20 °C)
- 溶解性In water, 15,200 mg/L at 25 °C
- 敏感性1.稳定性 稳定2.禁配物 强氧化剂、碱金属或活性金属粉末(如镁、铝等)、二甲亚砜等3.聚合危害 不聚合4.分解产物 溴化氢
- 外观形态无色气体带有一种像氯仿一样的气味
- 储存条件储存注意事项储存于阴凉、通风的有毒气体专用库房。远离火种、热源。库温不宜超过30°C。保持容器密封保存。应与氧化剂、活性金属粉末、食用化学品分开存放,切忌混储。采用防爆型照明、通风设施。禁止使用易产生火花的机械设备和工具。储区应备有泄漏应急处理设备。
- 产品应用农业上用作杀虫熏剂,冷冻剂.
- 性质描述常温下是无色气体,通常无臭,高浓度时具有类似氯仿的甜气味,有辛辣味.在空气中不易燃,但在氧中能燃烧.与空气形成爆炸性混合物,爆炸极限13.5-14.5(体积).水中溶解度(20°C,99.7kPa)1.75g/100g溶液.低于4°C时生成水合结晶CH3Br·20H2O.易溶于醇,氯仿,醚,二硫化碳,四氯化碳和苯.液体溴甲烷能与醇,醚,酮等混溶.熔点-93.66°C,沸点3.56°C.相对密度1.6755(20/4°C),1.730(0/14°C),20°C时的气体密度3.974g/L,折射率1.4432,折光率1.4218,黏度(0°C)0.397mPa·s,临界温度191°C,临界压力8.45MPa.溴化烷烃的化学性质活泼,而以溴甲烷为最能发生水解,氨化,氰化,成酯等反应,并随溴原子的增加,而性质趋于稳定.
MSDS等安全信息
- GHS象形图



- GHS符号GHS08 & GHS06 & GHS09;
注释: Health hazard & Skull and crossbones & Environment - 危险类别致突变性 类别2
急性毒性 类别3(吸入)
急性毒性 类别3(经口)
特定目标器官毒性 - 单次接触 类别3
特定目标器官毒性-重复接触 类别2
皮肤腐蚀/刺激 类别2
严重眼刺激 类别2
水生急性毒性 类别1
Ozone 1
Press. Gas (Comp.)
Flam. Gas 2
Press. Gas (Liq.)
急性毒性 类别2(吸入) - 警示词Danger(危险)
- 危险描述H341 |怀疑导致遗传缺陷.
H331 |吸入会中毒.
H301 |吞咽会中毒.
H335 |可能引起呼吸道刺激.
H373 |长期或反复接触可能损害器官.
H315 |造成皮肤刺激.
H319 |造成严重眼刺激.
H400 |对水生生物毒性极大.
H420 |破坏高层大气中的臭氧,危害公众健康和环境
H280 |含加压气体;加热可能会爆炸.
EUH059 |Hazardous to the ozone layer.
H221 |Flammable gas.
H330 |吸入致命. - 防范说明P203, P260, P261, P264, P264+P265, P270, P271, P273, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P330, P332+P317, P337+P317, P362+P364, P391, P403+P233, P405, P410+P403, and P501
- 危险等级2.3
- UN编号1062.0
- 危险品标志T:Toxic
- 安全声明S15-S27-S36/39-S38-S45-S59-S61-S36/37-S26-S24-S16-S7
- 危险类别码R36/37/38,R68,R59,R48/20,R50,R23/25
- WGK Germany3
欧盟法规
《欧盟PIC法规》统一分类与标签压力设备指令-第1组危险流体REACH注册ECHA物质食品接触材料-禁用CMR物质OtherC&L通报REACH预注册废弃物危险特性清单"欧盟管控危险化学品"工作场所安全标识要求ECHA物质化妆品禁用物质清单上下游产品
CAS号512-56-1 磷酸三甲酯 | CAS号108-38-3 间二甲苯 | CAS号34557-54-5 methane | CAS号95-63-6 1,2,4-三甲苯 | CAS号95-47-6 邻二甲苯 | CAS号581-42-0 2,6-二甲基萘 | CAS号106-42-3 对二甲苯 | CAS号75-25-2 三溴甲烷 | CAS号74-95-3 二溴甲烷 | CAS号108153-26-0 4-(3-HYDROXY-PR... | CAS号107-50-6 十四甲基环七硅氧烷 | CAS号541-05-9 六甲基环三硅氧烷 | CAS号556-67-2 八甲基环四硅氧烷 | CAS号541-02-6 环五聚二甲基硅氧烷 | CAS号540-97-6 十二甲基环六硅氧烷 | CAS号110625-47-3 2-(1,5-dimethyl... | CAS号108418-23-1 2-[4-(4-hexylbe... | CAS号1075-69-0 dimethyl(2-phen... | CAS号105752-56-5 1-methyl-3-nitr...磷酸三甲酯置于三溴化硼体系中,用 Chloroform-D1 作为反应溶剂,化学反应 24.0H,反应生成 溴甲烷
参考文献:Catalytic Cleavage Of Phosphate Ester Bonds By Boron Chelates
标题:Catalytic Cleavage Of Phosphate Ester Bonds By Boron Chelates
摘要:揭示了具有一般公式l{yxm}N的新化合物,其中x选自第13族元素,Y是卤素,L是含有至少一个与第13族元素接触的结合原子的螯合配体,所述原子选自c,N,O和s组成的组,M和n是至少为1的整数. L可以是席夫碱型配体,如salen配体.本发明的组合物可以是双齿,四齿或更多齿的.这些组合物可以用于磷酸酯或醚的去烷基化.优点是,本发明的方法可以具有催化性.
专利信息
专利号:US-9446995-B2
优先权日:2012-05-21
标 题:Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
发明人:CHONG HYUN-SOON
权利人:CHONG HYUN-SOON; ILLINOIS INST OF TECH
摘要:Stereoselective and regioselective synthesis of compounds via nucleophilic ring opening reactions of aziridinium ions for use in stereoselective and regioselective synthesis of therapeutic and diagnostic compounds.
专利号:US-11926589-B2
优先权日:2019-07-09
标 题 :Process for the synthesis of non-racemic cyclohexenes
发明人:REISMAN SARAH; ROMBOLA MICHAEL; LADD CAROLYN L; MCLAUGHLIN MARTIN JOHN; ZUEND STEPHAN; GOETZ ROLAND
权利人:BASF CORP; CALIFORNIA INST OF TECHN
摘要:This invention relates to a process for the synthesis of a non-racemic cyclohexene compound of formula (I) by a Diels-Alder reaction of a compound of formula (II) with a compound of formula (III) wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and Y have the meanings as defined in the description in the presence of a catalyst comprising at least one m-valent metal cation M m+ wherein the metal M is selected from Scandium (Sc), Yttrium (Y), Lanthanum (La), Cerium (Ce), Praseodymium (Pr), Neodymium (Nd), Promethium (Pm), Samarium (Sm), Europium (Eu), Gadolinium 15 (Gd), Terbium (Tb), Dysprosium (Dy), Holmium (Ho), Erbium (Er), Thulium (Tm), Ytterbium (Yb), Lutetium (Lu), Gallium (Ga) and Indium (In), and m is an integer of 1, 2 or 3, and a chiral ligand of the formula (IV) wherein R 10a , R 10b , R 10c , R 10d , R 10a′ , R 10b′ , R 10c′ , R 10d′ , Z and Z′ have the meanings as defined in the description.
专利号:WO-2021014395-A1
优先权日:2019-07-24
标题:Process for the synthesis of deuterated capsaicin, capsaicinoids and synthetic capsaicin analogs
发明人:ORUGANTI SRINIVAS; AMRUTAPU SRAVANTH KUMAR; SAMPATH MAGESH; SEN SAIKAT
权利人:DR REDDY’S INST OF LIFE SCIENCES
摘要:The present application provides novel processes for the synthesis of deuterated intermediates of capsaicinoids, particularly II, III, IV and V of capsaicinoids, relating to pharmaceutical applications. The invention also provides novel intermediates of compounds of formula IX, XIV, XV, XVI, XVII, XVIII, XX and XXI utilized in the process of making deuterated capsaicin II, III, IV and V.
专利号:US-2021107859-A1
优先权日:2018-04-06
标题 :A process for the synthesis of carbon labeled organic compounds
发明人:AUDISIO DAVIDE; CANTAT THIBAULT; DESTRO GIANLUCA
权利人:COMMISSARIAT ENERGIE ATOMIQUE
摘要:A process for the synthesis of a carbon labeled organic compound containing a carbon labeled carboxyl group is described. A method of using carbon labeled organic compounds containing a carbon labeled carboxyl group according to the present disclosure; a process for manufacturing labeled pharmaceuticals and agrochemicals comprising synthesis of carbon labeled organic compounds containing a carbon labeled carboxyl group according to the present disclosure; and a process for producing tracers comprising synthesis of carbon labeled organic compounds containing a carbon labeled carboxyl group according to the present disclosure are also described.
专利号:WO-9817677-A1
优先权日:1996-10-24
标 题 :Improvements in solid-phase synthesis of peptides and related compounds
发明人:ENGLEBRETSEN DARREN
权利人:UNIV QUEENSLAND; ENGLEBRETSEN DARREN
摘要:The invention relates to spacers for use in solid-phase synthesis of peptides and peptide-related compounds, in which a spacer construct is used to ensure that the target peptide or peptide-related compound is at a distance equivalent to at least 5-15 amino acids from the solid support. Constructs of the invention are particularly applicable to the synthesis of strongly hydrophobic peptide, which are otherwise difficult, if not impossible to purify and analyse. The constructs and methods of the invention are also applicable to synthesis of peptide nucleic acids.
专利号:US-9126995-B2
优先权日:2011-11-08
标题:Method for catalytic asymmetric synthesis of optically active isoxazoline compound and optically active isoxazoline compound
发明人:TOYAMA KEN-ICHI; MORIYAMA YUJI; MATOBA KAZUTAKA; YAOSAKA MANABU; IKEDA EITATSU
权利人:NISSAN CHEMICAL IND LTD
摘要:There is provided a method for catalytic asymmetric synthesis of optically active isoxazoline compound and an optically active isoxazoline compound. A method for catalytic asymmetric synthesis of optically active isoxazoline compound of a formula (6) including reacting an α,β-unsaturated carbonyl compound of a formula (1) and a hydroxylamine in a solvent in the presence of a base by adding a chiral phase transfer catalyst. An optically active isoxazoline compound of a formula (13) that can be synthesized by the method.